6 completed, 3 not yet recruiting, 3 unknown. 10 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 10 | Completed 6, Unknown 3, Not yet recruiting 1 |
Follow Abbott Rapid Dx: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dengue - Sample Collection Study Pakistan Dengue | Not yet recruiting | Abbott Rapid Dx | 200 | 2025-10-01 | 2025-10-02 | |
| Clinical Feasibility of the BinaxNOW™ COVID-19/Flu A&B Combo in the Southern Hemisphere BinaxNOW™ COVID-19/Flu A&B Combo Self-Test - Influenza Type A, Influenza Type B | Not applicable | Not yet recruiting | Abbott Rapid Dx | 700 | 2025-06-30 | 2025-04-15 |
| Lay User Evaluation of the Panbio™ HCV Self Test in an EU Population Panbio™ HCV Self Test - Hepatitis C | Not yet recruiting | Abbott Rapid Dx | 150 | 2024-12-01 | 2024-11-22 | |
| Lay User Evaluation of the Panbio™ HCV Self-Test Panbio™ HCV Self Test - HEPATITIS C (HCV) | Not applicable | Unknown | Abbott Rapid Dx | 1185 | 2024-10-01 | 2024-09-20 |
| Evaluation of the Diagnostic Sensitivity and Specificity of the Determine™ Syphilis Advanced Test. Diagnostic test: Determine™ Syphilis Advanced test - Syphilis Infection | Not applicable | Unknown | Abbott Rapid Dx | 400 | 2024-09-01 | 2024-09-04 |
| Clinical Evaluation of the ID NOW™ CT/NG Test ID NOW™ - Chlamydia Trachomatis Infection, Neisseria Gonorrheae Infection | Not applicable | Unknown | Abbott Rapid Dx | 7100 | 2024-07-09 | 2024-05-02 |
| Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel to Support Home Use Panbio™ COVID-19/Flu A&B Panel - COVID-19, Influenza A | Not applicable | Completed | Abbott Rapid Dx | 624 | 2023-12-04 | 2024-08-19 |
| Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel Panbio™ - COVID-19, Influenza A | Not applicable | Completed | Abbott Rapid Dx | 447 | 2023-11-14 | 2024-04-25 |
| Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Rapid Panel Professional Use Device and the Panbio™ COVID-19/Flu A&B Rapid Panel Self-Test Device Panbio™ - COVID-19, Influenza A | Not applicable | Completed | Abbott Rapid Dx | 903 | 2023-01-06 | 2023-11-09 |
| Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Rapid Panel Professional Use Product Using Mid-Turbinate Nasal Swabs Panbio™ - COVID-19, Influenza A | Not applicable | Completed | Abbott Rapid Dx | 1129 | 2022-12-15 | 2023-11-09 |
| Performance Evaluation of Malaria Plus Rapid Diagnostic Tests (RDTs) for the Detection of Plasmodium Infections in Patients With Symptoms Suggestive of Malaria NxTekTM Malaria Pf Plus Rapid Diagnostic Test Device - Malaria | Not applicable | Completed | Abbott Rapid Dx | 1023 | 2022-05-24 | 2023-04-24 |
| Sample Collection for Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel. Nasal and Nasopharyngeal Sampling of the Panbio™ COVID-19/ Flu A&B Rapid Panel - COVID-19, Influenza A | Not applicable | Completed | Abbott Rapid Dx | 676 | 2022-03-14 | 2023-11-09 |
COVID-19 (6) · Hepatitis C (2) · Asymptomatic Diseases (1) · Dengue (1) · Gonorrhea (1) · Malaria (1) · Malaria, Falciparum (1) · Malaria, Vivax (1)
United States (6) · Ethiopia (1) · Spain (1) · Uganda (1)
Dr. Lemu Golassa, PhD (1) · Huma Qureshi, MD (1) · Mohammed Majam, BSc, MBA (1) · Pablo Ryan, MD, PhD (1) · Pontiano Kaleebu, Professor, MD PhD (1) · Saeed Hamid, Pr (1)